STAT1 and neoplasm: In addition, it has been shown to have anti-tumor effects through signaling in mesenchymal stromal cells (MSCs), although this occurs following the switching of STAT1 homodimers to STAT1:STAT2 heterodimers in response to interferon-α (IFNα) [58].